1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer
    Meeting Abstract

    Marco, M.; Chen, C. T.; Choi, S. H.; Pelossof, R.; Shia, J.; Garcia-Aguilar, J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of plasma KRAS as a prognostic biomarker in localized pancreas ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Gedvilaite, E.; Chou, J. F.; Capanu, M.; You, D.; Yu, K. H.; Varghese, A. M.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; Tsui, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma
    Meeting Abstract

    McIntyre, C. A.; Lawrence, S. A.; Wong, W.; Chou, J. F.; Capanu, M.; Berger, M. F.; Allen, P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Belatacept interference with B-cell cross-matching, consideration for desensitization protocols using co-sitmulatory blockade
    Meeting Abstract

    Blouin, A. G.; Vlad, G.
    Human Immunology (2019)

    Fulltext@MSK | Save
  • Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Karthaus, W.; Mota, J. M.; Mu, P.; Wu, C.; Abida, W.; Linton, E.; Lee, Y. S.; Lee, E.; Mao, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial
    Meeting Abstract

    Won, H. H.; Selcuklu, S. D.; Piha-Paul, S. A.; Saura, C.; Rodon, J.; Mayer, I. A.; Loi, S.; Shapiro, G. I.; Lu, J.; Brufsky, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Enhancing apoptosis to improve the therapy of EGFR-mutant lung cancer
    Meeting Abstract

    Tanaka, K.; Han, S.; Ganesan, Y. T.; Hsieh, J. J.; Cheng, E. H.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective clinical sequencing distinguishes independent primary cancers from recurrent or metastatic disease
    Meeting Abstract

    Schram, A. M.; Bandlamudi, C.; Zehir, A.; Ladanyi, M.; Berger, M. F.; Taylor, B. S.; Hyman, D. M.
    Cancer Research (2019)

    Fulltext@MSK | Save